MENU

Metabolon’s Shanghai Jiao Tong University Lab Receives Validation

05/10/12

Metabolon’s Shanghai Jiao Tong University Lab Receives Validation

RESEARCH TRIANGLE PARK, N.C. (May 10, 2012) — Metabolon, Inc., a diagnostics and services company offering the industry’s leading biochemical profiling technology, announced today that in collaboration with Shanghai Jiao Tong University (SJTU), Metabolon has successfully implemented its technology platform in China. The SJTU-Metabolon Joint Metabolomics Laboratory passed various stringent quality control processes and has officially started operation. This allows Metabolon to work with academic and industrial scientists within China or other Asian countries to perform biochemical profiling experiments with Metabolon’s technology.

“The successful launch of the joint lab is a vital step in bringing the science of metabolomics to a significant, untapped market,” states Metabolon CEO John Ryals. “Our partnership with Shanghai Jiao Tong University is a further proof of Metabolon’s efforts to bring personalized medicine and metabolic biomarker research to all parts of the world. We were able to completely replicate our complex mass spectrometry based methods in a remote location due to our highly engineered and quality controlled process. This will open up expansion possibilities for Metabolon to service previously difficult to access markets across the globe”.

About Metabolon

Metabolon, Inc. has advanced the field of metabolomics by pioneering and patenting the industry’s leading biochemical biomarker discovery and profiling platform. It has developed the technology to quickly identify and measure all of the biochemicals in a biological sample through its proprietary global processing method. Through the generation and interpretation of data, this method provides a precise understanding of disease etiology and drug action, and advances personalized medicine beyond what genomics and other approaches can promise. Metabolon’s expertise is being embraced by a wide range of pharmaceutical, biotechnology, food and agricultural companies. Metabolytics, its biomarker discovery and analysis business, has completed over 450 client studies and processed over 50,000 samples for customers in 2011 alone. Building on its expertise in biochemistry understanding, Metabolon is also developing proprietary diagnostic tests to determine and track disease progression. For more information about Metabolon, please visit www.metabolon.com or contact Matt Zaske at mzaske@metabolon.com or 919-595-2200.

SJTU-Metabolon Joint Metabolomics Laboratory
Prof. Dabing Zhang
Rm. 104, Bldg 1, School of Life Sciences and Biotechnology
Shanghai Jiaotong University
800 Dongchuan Rd.
Shanghai, China 200240
sjtumetabolic@sjtu.edu.cn
http://ncmcg.sjtu.edu.cn/metabolomics

Media Contact:
LHA
Mackenzie Mills
mmills@lhai.com
212-838-3777